| Antibody-targeted biodegradable nanoparticles for cancer therapy VH Shargh, H Hondermarck, M Liang Nanomedicine 11 (1), 63-79, 2016 | 114 | 2016 |
| Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends A Badiee, VH Shargh, A Khamesipour, MR Jaafari Vaccine 31 (5), 735-749, 2013 | 98 | 2013 |
| The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen A Badiee, A Khamesipour, A Samiei, D Soroush, VH Shargh, MT Kheiri, ... Experimental parasitology 132 (4), 403-409, 2012 | 89 | 2012 |
| Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA) H Firouzmand, A Badiee, A Khamesipour, VH Shargh, SH Alavizadeh, ... Acta tropica 128 (3), 528-535, 2013 | 63 | 2013 |
| Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis VH Shargh, MR Jaafari, A Khamesipour, I Jaafari, SA Jalali, A Abbasi, ... Vaccine 30 (26), 3957-3964, 2012 | 61 | 2012 |
| Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis V Heravi Shargh, MR Jaafari, A Khamesipour, SA Jalali, H Firouzmand, ... Parasitology research 111, 105-114, 2012 | 48 | 2012 |
| Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model I Jafari, VH Shargh, M Shahryari, A Abbasi, MR Jaafari, A Khamesipour, ... Immunobiology 223 (6-7), 493-500, 2018 | 20 | 2018 |
| Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy VH Shargh, H Hondermarck, M Liang Nanomedicine (Lond)., 2017 | 14 | 2017 |
| Chemosensitization of temozolomide-resistant pediatric diffuse midline glioma using potent nanoencapsulated forms of a N (3)-propargyl analogue VH Shargh, J Luckett, K Bouzinab, S Paisey, L Turyanska, WGB Singleton, ... ACS Applied Materials and Interfaces 13 (30), 35266-35280, 2021 | 11 | 2021 |
| Chemosensitization of temozolomide-resistant pediatric diffuse midline glioma using potent nanoencapsulated forms of a N (3)-propargyl analogue V Heravi Shargh, J Luckett, K Bouzinab, S Paisey, L Turyanska, ... ACS Applied Materials & Interfaces 13 (30), 35266-35280, 2021 | 10 | 2021 |
| Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion VH Shargh, H Hondermarck, M Liang International Journal of Pharmaceutics 515 (1-2), 527-534, 2016 | 10 | 2016 |
| Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy A Askarizadeh, M Mashreghi, E Mirhadi, F Mirzavi, VH Shargh, A Badiee, ... Cancer nanotechnology 14 (1), 18, 2023 | 9 | 2023 |
| Surface-modified cationic liposomes with a matrix metalloproteinase-degradable polyethylene glycol derivative improved doxorubicin delivery in murine colon cancer A Askarizadeh, M Mashreghi, E Mirhadi, A Mehrabian, V Heravi Shargh, ... Journal of Liposome Research, 1-18, 2023 | | 2023 |
| MULTIFUNCTIONAL NANOMEDICINES BASED ON ALBUMIN FOR TARGETED BREAST CANCER THERAPY VH Shargh The University of Newcastle, Australia, 2016 | | 2016 |
| ENHANCING THE EFFICACY OF TYROSINE KINASE INHIBITORS THROUGH BIO-POLYMERIC ALBUMIN HYBRID NANOPARTICLES IN BREAST CANCER VH Shargh, H Hondermarck, M Liang ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 11, 16-16, 2015 | | 2015 |
